[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100595192":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":19,"centralContacts":24,"locations":34,"responsibleParty":52,"collaborators":10,"id":54,"slug":55,"hasResults":56,"nctId":57,"briefTitle":58,"officialTitle":59,"acronym":10,"eligibilityCriteria":60,"healthyVolunteers":56,"sex":61,"minAge":62,"maxAge":10,"enrollmentInfo":63,"targetDuration":10,"studyType":66,"phases":10,"briefSummary":67,"conditions":68,"keywords":10,"overallStatus":36,"whyStopped":10,"lastUpdateSubmitDate":70,"lastUpdatePostDateStruct":71,"startDateStruct":74,"completionDateStruct":76,"leadSponsor":78,"locationsCount":79},{"fullName":5,"class":6},"Mayo Clinic","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Observational",null,"Patients undergo standard of care radical cystectomy and residual tissues collected undergo US core needle biopsy. Additionally, patients have their medical records reviewed on study.",[13],"Other: Non-Interventional Study",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"Non-Interventional Study","Non-interventional study",[9],[20],{"name":21,"affiliation":22,"role":23},"Vidit Sharma, MD","Mayo Clinic in Rochester","PRINCIPAL_INVESTIGATOR",[25,30],{"name":26,"role":27,"phone":28,"phoneExt":10,"email":29},"Hosanna Yeadon, BA","CONTACT","507-538-5019","biffert.hosanna@mayo.edu",{"name":31,"role":27,"phone":32,"phoneExt":10,"email":33},"Clinical Trials Referral Office","855-776-0015","mayocliniccancerstudies@mayo.edu",[35],{"facility":22,"status":36,"city":37,"state":38,"zip":39,"country":40,"countryCode":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":48},"RECRUITING","Rochester","Minnesota","55905","United States","US",{"type":43,"coordinates":44},"Point",[45,46],-92.4699,44.02163,{"lat":46,"lon":45},[49,50,51],{"name":26,"role":27,"phone":28,"phoneExt":10,"email":29},{"name":31,"role":27,"phone":32,"phoneExt":10,"email":33},{"name":21,"role":23,"phone":10,"phoneExt":10,"email":10},{"type":53,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100595192","ultrasound-guided-core-needle-biopsy-to-stage-urothelial-carcinoma-of-the-bladder-us-ucb-100595192",false,"NCT07029256","Ultrasound-Guided Core Needle Biopsy to Stage Urothelial Carcinoma of the Bladder (US UCB)","Ultrasound-Guided Core Needle Biopsy to Stage Urothelial Carcinoma of the Bladder","Inclusion Criteria:\n\n* Undergoing radical cystectomy for confirmed or suspected urothelial carcinoma of the bladder\n* Prior abdominal imaging\n\nExclusion Criteria:\n\n* History of partial cystectomy or complex bladder reconstruction or substitution (i.e. bladder augment or urothelial recurrence in a neobladder)","ALL","18 Years",{"count":64,"type":65},100,"ESTIMATED","OBSERVATIONAL","This study is being done to test the feasibility and accuracy of using an ultrasound-guided core needle biopsy technique as a potential tool for staging urothelial carcinoma of the bladder (UCB).",[69],"Bladder Urothelial Carcinoma","2026-06-08",{"date":72,"type":73},"2026-06-10","ACTUAL",{"date":75,"type":73},"2024-07-26",{"date":77,"type":65},"2030-07-30",{"name":5,"class":6},1]